1. Home
  2. IBRX vs TTEK Comparison

IBRX vs TTEK Comparison

Compare IBRX & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.41

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

HOLD

Current Price

$31.13

Market Cap

7.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
TTEK
Founded
2014
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
7.9B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
IBRX
TTEK
Price
$7.41
$31.13
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$12.57
$44.00
AVG Volume (30 Days)
14.7M
2.2M
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
0.83%
EPS Growth
38.71
N/A
EPS
N/A
0.40
Revenue
$113,288,000.00
$2,964,148,000.00
Revenue This Year
$88.59
N/A
Revenue Next Year
$131.15
$6.43
P/E Ratio
N/A
$78.33
Revenue Growth
668.31
7.66
52 Week Low
$1.83
$29.57
52 Week High
$12.43
$43.14

Technical Indicators

Market Signals
Indicator
IBRX
TTEK
Relative Strength Index (RSI) 46.98 45.07
Support Level $2.22 $29.72
Resistance Level $8.28 $34.96
Average True Range (ATR) 0.56 0.94
MACD 0.06 0.19
Stochastic Oscillator 39.03 53.32

Price Performance

Historical Comparison
IBRX
TTEK

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

Share on Social Networks: